Cystic Fibrosis News

molecule
A new molecule could significantly reduce the cycles of airway inflammation and infection that eventually result in fatal destruction of the lungs in people with cystic fibrosis.
cystic fibrosis newborn screening
A new study led by a team from the Research Institute of the McGill University Health Centre and Cystic Fibrosis Canada supports the benefits of newborn screening programs for cystic fibrosis.
dr larry sands CF study
A new study led by a team from the Research Institute of the McGill University Health Centre and Cystic Fibrosis Canada reinforces the benefits of newborn screening for cystic fibrosis patients.
lung liver transplant surgery
Josiah Ferrell, a 25-year-old cystic fibrosis patient, received a dual lung and liver transplant and is the first patient to undergo the procedure in North Texas.
3d lung image
Recent data suggests that the sticky mucus found in cystic fibrosis patients is more viscous because the thin layer coating the airways is more acidic.
cystic fibrosis drug
The antimicrobial agent Mul-1867 for the treatment of bacterial lung infections in cystic fibrosis patients has been granted Orphan Drug Designation by the FDA.
raptor logo
Raptor Pharmaceutical Corp has announced its first commercial sale of Quinsair, a levofloxacin inhalation solution for cystic fibrosis treatment, in Germany and Denmark.
3d-lung-image-350
RT consulted with some leading device manufacturers about today’s airway clearance products and the industry and technology trends in the next few years.
kalydeco cystic fibrosis
Ivacaftor (Kalydeco) treatment improves airway flexibility and capacity in patients with cystic fibrosis, according to a new study.
bronchi-3d-575
Symptoms of Scedosporium apiospermum colonization in patients with cystic fibrosis may resemble symptoms of plastic bronchitis, according to research.
microscope-sample-research-ab-500
Nivalis Therapeutics has reached the halfway point in dosing of the 135 patient Phase 2 clinical trial evaluating N91115, an investigational drug and first-in-class stabilizer of the CFTR protein.
hispanic-child-school-500
The Cystic Fibrosis Foundation has issued new clinical practice guidelines for the treatment of preschoolers suffering from CF. The guidelines were published in the journal Pediatrics.
vertex
The Indian Patent Office has refused a patent to Vertex Pharmaceuticals for its cystic fibrosis drug Orkambi.
CF treatment study
An ongoing study will explore tailored medical care and treatment for patients with cystic fibrosis.
bacteria-petri-500
Volatile compounds released by bacterial pathogen Pseudomonas aeruginosa can trigger the growth of fungal pathogen Aspergillus fumigatus, often found in cystic fibrosis patients.
FDA approval raptor
The FDA has granted Qualified Infectious Disease Product designation to MP-376, Raptor Pharmaceutical’s inhaled levofloxacin to treat pulmonary infections.
viral infection CF patients
New data reveals that viral infections in cystic fibrosis patients are linked to pulmonary exacerbations.
CF lung infection
A new review by the University of Liverpool examines the recent research progress into how P. aeruginosa adapts and evolves in chronically infected cystic fibrosis patients.
Secretion_RespirTech_inCourage-500
RespirTech has introduced a new remote monitoring system that wirelessly transmits spirometry and HFCC airway clearance data for treatment of cystic fibrosis patients.
liver disorder CF
Hepatopulmonary syndrome may be under diagnosed in at-risk patients with cystic fibrosis, according to a study.